Spots Global Cancer Trial Database for peritoneal carcinomatosis
Every month we try and update this database with for peritoneal carcinomatosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors | NCT03252938 | Solid Tumors Peritoneal Carc... | IMP321 Avelumab | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies | NCT02823860 | Digestive Perit... | Collection of b... | 18 Years - | Hospices Civils de Lyon | |
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors | NCT02604784 | Peritoneal Carc... | Pressurized Int... Pressurized Int... | 18 Years - 78 Years | Fondazione del Piemonte per l'Oncologia | |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 | NCT03618758 | Gastric Cancer ... Peritoneal Carc... Intraperitoneal... mFOLFOX6 | Paclitaxel mFOLFOX6 regime... | 20 Years - 79 Years | Seoul National University Bundang Hospital | |
| PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis | NCT04000906 | Peritoneal Carc... | Nab paclitaxel Cisplatin | 18 Years - | University Hospital, Geneva | |
| Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients | NCT05300789 | Peritoneal Carc... Colon Cancer | Follow-up | 18 Years - | Hospital San Carlos, Madrid | |
| Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer | NCT05652348 | Gastric Cancer Colon Cancer Peritoneal Carc... | Establishment o... | 18 Years - | Technische Universität Dresden | |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- | NCT04595929 | Peritoneal Carc... Gastric Cancer | Staging laparos... 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Radical surgery PIPAC Adjuvant chemot... | 18 Years - 65 Years | St. Petersburg State Pavlov Medical University | |
| Surgery and Heated Chemotherapy for Adrenocortical Carcinoma | NCT01833832 | Adrenocortical ... Peritoneal Carc... | Cisplatin Cytoreductive s... sodium thiosulf... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) | NCT03100708 | Peritoneal Carc... | PIPAC | 18 Years - | University of Leipzig | |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer | NCT03253939 | Gastric Cancer Peritoneal Carc... | Cytoreductive s... Cytoreductive s... | 18 Years - 95 Years | Hospices Civils de Lyon | |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00825201 | Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom... | 19 Years - | City of Hope Medical Center | |
| Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses | NCT04108936 | Peritoneal Carc... | 18 Years - 80 Years | University of Regensburg | ||
| Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy | NCT03364907 | Peritoneal Carc... | HIPEC with flus... HIPEC without f... | 18 Years - | Radboud University Medical Center | |
| Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis | NCT04547725 | Gastric Cancer Peritoneal Carc... | CRS followed by... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | NCT03150628 | Gastric Cancer Peritoneal Carc... HIPEC | Perioperative c... Cytoreduction HIPEC | 18 Years - | UMC Utrecht | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed | NCT01617382 | Peritoneal Carc... Pseudomyxoma Pe... Peritoneal Meso... | - | Universitaire Ziekenhuizen KU Leuven | ||
| A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis | NCT01443260 | Peritoneal Carc... | GL-ONC1 | 18 Years - | Genelux Corporation | |
| Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases | NCT05371223 | Peritoneal Carc... Pancreas Neopla... | Combined Nabpac... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences | NCT01685632 | Peritoneal Carc... | Surgery with IP... Without surgery... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | NCT04898842 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Ovarian Cancer Ovarian Neoplas... Metastatic Colo... Metastatic Ovar... Peritoneal Carc... Bowel Obstructi... | Dietary interve... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer | NCT01379482 | Peritoneal Carc... Gastric Cancer | Multimodal trea... | - 80 Years | Uppsala University | |
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors | NCT03252938 | Solid Tumors Peritoneal Carc... | IMP321 Avelumab | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis | NCT02399410 | Colorectal Neop... | perioperative c... cytoreductive s... Intraperitoneal... | 18 Years - | University Hospital, Ghent | |
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors | NCT03252938 | Solid Tumors Peritoneal Carc... | IMP321 Avelumab | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) | NCT03682744 | Peritoneal Carc... Peritoneal Meta... Colorectal Canc... Gastric Cancer Breast Cancer Pancreas Cancer Carcinoembryoni... | anti-CEA CAR-T ... | 18 Years - | Sorrento Therapeutics, Inc. | |
| Treating Peritoneal Carcinomatosis With PIPAC | NCT02320448 | Peritoneal Carc... | PIPAC | 18 Years - | Odense University Hospital | |
| Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma. | NCT05687617 | Gastric Cancer Gastric Adenoca... Peritoneal Carc... Peritoneal Meta... | Indocyanine gre... | 18 Years - | Laval University | |
| Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia | NCT02739698 | Peritoneal Carc... | Paclitaxel Radical surgery... | 18 Years - 75 Years | Maimónides Biomedical Research Institute of Córdoba | |
| Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer | NCT02032485 | Colorectal Canc... Peritoneal Carc... | Indocyanine Gre... | 18 Years - | Jules Bordet Institute | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination | NCT04797923 | Advanced Gastri... Peritoneal Carc... | 1. Treatment: I... 2. Response eva... | 19 Years - 75 Years | Gangnam Severance Hospital | |
| Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) | NCT03875144 | Peritoneal Meso... Peritoneal Carc... | PIPAC Cisplatin Pemetrexed | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis | NCT01342653 | Peritoneal Carc... Gastric Cancer | Intraperitoneal... | 18 Years - 64 Years | Hospital General Universitario Gregorio Marañon | |
| Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis | NCT04024917 | Peritoneal Carc... Pseudomyxoma Pe... Mesothelioma Pe... | Cardiac coheren... Standard care | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer | NCT00769405 | Colorectal Canc... Primary Periton... | fluorouracil leucovorin calc... oxaliplatin hyperthermia tr... | 18 Years - 70 Years | UNICANCER | |
| Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) | NCT03875144 | Peritoneal Meso... Peritoneal Carc... | PIPAC Cisplatin Pemetrexed | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 | NCT03618758 | Gastric Cancer ... Peritoneal Carc... Intraperitoneal... mFOLFOX6 | Paclitaxel mFOLFOX6 regime... | 20 Years - 79 Years | Seoul National University Bundang Hospital | |
| Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis | NCT02024841 | Gastric Cancer Peritoneal Carc... | Intraperitoneal... | 18 Years - | The University of Hong Kong | |
| Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | NCT01764789 | Anxiety Disorde... Depression Fatigue Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pain Peritoneal Carc... Pseudomyxoma Pe... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Gesta... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... | questionnaire a... quality-of-life... psychosocial as... behavioral inte... cognitive inter... educational int... | 21 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
| A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination | NCT04797923 | Advanced Gastri... Peritoneal Carc... | 1. Treatment: I... 2. Response eva... | 19 Years - 75 Years | Gangnam Severance Hospital | |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis | NCT00454519 | Stomach Neoplas... Colorectal Neop... Neoplasm Metast... Mesothelioma | cytoreductive s... intraoperative ... | 20 Years - 70 Years | Wuhan University | |
| PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer | NCT04329494 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Malignant Uteri... Metastatic Appe... Metastatic Colo... Metastatic Gast... Metastatic Mali... Metastatic Mali... Metastatic Ovar... Pathologic Stag... Peritoneal Carc... Postneoadjuvant... Stage IV Append... Stage IV Colore... Stage IV Ovaria... Stage IV Uterin... Stage IVA Appen... Stage IVA Color... Stage IVA Ovari... Stage IVA Uteri... Stage IVB Appen... Stage IVB Color... Stage IVB Ovari... Stage IVB Uteri... Stage IVC Appen... Stage IVC Color... | Biopsy Cisplatin Doxorubicin Fluorouracil Intraperitoneal... Irinotecan Leucovorin Mitomycin Oxaliplatin Quality-of-Life... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer | NCT05644249 | Gastric Cancer Peritoneal Carc... | Combined Doxoru... | 18 Years - | Vilnius University | |
| Combined Anticancer Treatment of Advanced Colon Cancer | NCT01540344 | Peritoneal Carc... Colorectal Canc... | CRS HIPEC | 18 Years - 71 Years | University of Regensburg | |
| Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies | NCT02823860 | Digestive Perit... | Collection of b... | 18 Years - | Hospices Civils de Lyon | |
| Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial | NCT04475159 | Metastatic Colo... Peritoneal Carc... Colon Adenocarc... | Pressurized Int... | 18 Years - | Sheba Medical Center | |
| Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis | NCT02179489 | Malignant Neopl... Peritoneal Carc... | Surgery and Hyp... | 18 Years - 75 Years | Zhejiang University | |
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer | NCT04107077 | Gastric Cancer Peritoneal Carc... | Cisplatin Mitomycin | 18 Years - | University of Chicago | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer | NCT01264432 | Adult Solid Neo... Peritoneal Carc... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | Laboratory Biom... Quality-of-Life... Radiation Thera... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic. | NCT03798132 | Peritoneal Carc... | laparoscopy | 18 Years - 100 Years | South Egypt Cancer Institute | |
| Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis | NCT04547725 | Gastric Cancer Peritoneal Carc... | CRS followed by... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | NCT02891447 | Gastric Adenoca... Gastroesophagea... Peritoneal Carc... | Cisplatin Hyperthermic In... Mitomycin | 18 Years - | M.D. Anderson Cancer Center | |
| Combined Anticancer Treatment of Advanced Colon Cancer | NCT01540344 | Peritoneal Carc... Colorectal Canc... | CRS HIPEC | 18 Years - 71 Years | University of Regensburg | |
| A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis | NCT04047771 | Peritoneal Carc... | SCB-313 | 18 Years - 75 Years | Sichuan Clover Biopharmaceuticals, Inc. | |
| The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer. | NCT05752357 | Carcinoma | 20 Years - | Chang Gung Memorial Hospital | ||
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer | NCT04107077 | Gastric Cancer Peritoneal Carc... | Cisplatin Mitomycin | 18 Years - | University of Chicago | |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer | NCT03253939 | Gastric Cancer Peritoneal Carc... | Cytoreductive s... Cytoreductive s... | 18 Years - 95 Years | Hospices Civils de Lyon | |
| Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study | NCT04734691 | Peritoneal Carc... | PIPAC | 18 Years - 75 Years | University Hospital, Geneva | |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) | NCT05913674 | Peritoneal Carc... Appendiceal Neo... Colorectal Canc... | Modified early ... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) | NCT03100708 | Peritoneal Carc... | PIPAC | 18 Years - | University of Leipzig | |
| Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- | NCT04595929 | Peritoneal Carc... Gastric Cancer | Staging laparos... 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Radical surgery PIPAC Adjuvant chemot... | 18 Years - 65 Years | St. Petersburg State Pavlov Medical University | |
| Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis | NCT02179489 | Malignant Neopl... Peritoneal Carc... | Surgery and Hyp... | 18 Years - 75 Years | Zhejiang University | |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis | NCT05395910 | Peritoneal Carc... | Paclitaxel | 21 Years - 99 Years | National University Hospital, Singapore | |
| Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI | NCT02833753 | Colorectal Canc... Appendix Cancer Peritoneal Carc... | Oxaliplatin | 18 Years - 99 Years | University of Massachusetts, Worcester | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism | NCT02803515 | Peritoneal Carc... | peripheral veno... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis | NCT03777943 | Peritoneal Carc... | Sampling perito... | 18 Years - | University Hospital, Ghent | |
| Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer | NCT04231175 | Colorectal Canc... Peritoneal Carc... MRI | DWI MRI of the ... | 18 Years - | The Netherlands Cancer Institute | |
| Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas | NCT01504256 | Gastric Adenoca... Siewert Type II... Siewert Type II... | catumaxomab, Fl... Fluorouracil, l... | 18 Years - | AIO-Studien-gGmbH | |
| Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer | NCT02784028 | Peritoneal Carc... | SGM-101 | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Galunisertib Combined With Capecitabine in Advanced CRC With PM | NCT05700656 | Colorectal Canc... Peritoneal Carc... | Galunisertib pl... | 18 Years - | The Netherlands Cancer Institute | |
| Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer | NCT01476553 | Adenocarcinoma Stomach Neoplas... | Extensive Intra... | 18 Years - | Universitätsmedizin Mannheim | |
| Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index | NCT05063019 | Hyperthermic In... Cytoreductive S... Peritoneal Carc... | MRI | 20 Years - 80 Years | Chang Gung Memorial Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
